- Home
- RCUS vs COHU Comparison
RCUS vs COHU Comparison
Compare RCUS & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- COHU
- Stock Information
- Founded
- RCUS 2015
- COHU 1947
- Country
- RCUS United States
- COHU United States
- Employees
- RCUS N/A
- COHU N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- COHU Electrical Products
- Sector
- RCUS Health Care
- COHU Industrials
- Exchange
- RCUS Nasdaq
- COHU Nasdaq
- Market Cap
- RCUS 906.4M
- COHU 846.8M
- IPO Year
- RCUS 2018
- COHU N/A
- Fundamental
- Price
- RCUS $8.54
- COHU $19.72
- Analyst Decision
- RCUS Buy
- COHU Buy
- Analyst Count
- RCUS 10
- COHU 7
- Target Price
- RCUS $23.75
- COHU $29.50
- AVG Volume (30 Days)
- RCUS 1.2M
- COHU 395.0K
- Earning Date
- RCUS 08-07-2025
- COHU 07-30-2025
- Dividend Yield
- RCUS N/A
- COHU N/A
- EPS Growth
- RCUS N/A
- COHU N/A
- EPS
- RCUS N/A
- COHU N/A
- Revenue
- RCUS $141,000,000.00
- COHU $390,962,000.00
- Revenue This Year
- RCUS N/A
- COHU $10.84
- Revenue Next Year
- RCUS $28.73
- COHU $14.84
- P/E Ratio
- RCUS N/A
- COHU N/A
- Revenue Growth
- RCUS N/A
- COHU N/A
- 52 Week Low
- RCUS $6.50
- COHU $12.57
- 52 Week High
- RCUS $18.98
- COHU $36.60
- Technical
- Relative Strength Index (RSI)
- RCUS 46.40
- COHU 62.52
- Support Level
- RCUS $7.92
- COHU $18.92
- Resistance Level
- RCUS $8.61
- COHU $19.97
- Average True Range (ATR)
- RCUS 0.45
- COHU 0.66
- MACD
- RCUS -0.09
- COHU 0.04
- Stochastic Oscillator
- RCUS 40.00
- COHU 88.94
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About COHU Cohu Inc.
Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).